Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
VISEN Pharmaceuticals ( (HK:2561) ) just unveiled an announcement.
VISEN Pharmaceuticals has announced its financial results for the year ended December 31, 2024. The preliminary results were included in the company’s prospectus dated March 13, 2025, and are available on the Stock Exchange and company websites. This announcement is part of the company’s compliance with the listing rules, and it highlights the company’s transparency and adherence to regulatory requirements.
More about VISEN Pharmaceuticals
VISEN Pharmaceuticals is a company incorporated in the Cayman Islands, operating in the pharmaceutical industry. It is listed on the Stock Exchange of Hong Kong and focuses on developing and providing pharmaceutical products.
YTD Price Performance: -21.37%
Average Trading Volume: 1,372,877
See more data about 2561 stock on TipRanks’ Stock Analysis page.